Anti-fungal Treatment Market Trends, Emerging Audience, Segments, Profits and Competitor Landscape
The Anti-Fungal Treatment Market Insights and Analysis by Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Pyrimidines), Therapeutic Indication (Systemic, Candidiasis, Cryptococcosis, Prophylactic Use of Antifungals, Coccidioidomycosis), Pathogen (Candid, Aspergillus, Cryptococcus, CoccidiodiesImmitis, Zygomycetes, Trichophyton), End Users (Hospitals & Clinics, Dermatology Clinics) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2032
The global antifungal treatment market has been assessed to grow significantly over the forecast period owing to influential factors such as the increase in the prevalence of fungal infections such as athlete's foot, ringworm infection, severe systemic infections, and others, which has driven the demand and availability of their treatment.
The global anti-fungal treatment market is projected to reach USD 18.9 Billion by 2030 at a 6.1% CAGR during the forecast period of 2023 to 2032.
Rising prevalence of immunological disease and availability of a wide range of treatment products have increased the growth of the global market for antifungal treatment. additionally, growing awareness about the side effects of conventional drugs and the availability of improved drugs support the growth of the market.
The global antifungal treatment market was growing moderately and expected to grow at the same pace over the forecast period 2017 to 2023. An increase in the patient population and geriatric population prone to fungal diseases and the growing prevalence of HIV virus infections are essential factors influencing the market growth of the global antifungal treatment market.
Segmental analysis
The global antifungal treatment market is segmented based on drug class, therapeutic indication, pathogen, end user, and region.
On the basis of drug class, the antifungal treatment market trends have been segmented into allylamines, azoles, echinocandins, polyenes, pyrimidines, and others.
Based on therapeutic indication, the market has been segmented into candidiasis, coccidioidomycosis, cryptococcosis, and systemic. The systemic segment has been assessed to grow at the highest CAGR and accounted for the largest market share over the forecast period.
On the basis of the pathogen, the market is segmented into candida, Aspergillus, coccidioides immitis, Cryptococcus, Trichophyton, zygomycetes, and others.
On the basis of the end user, the market has been segmented into dermatology clinics, hospitals & clinics, and other users.
Based on region, the global antifungal treatment market has been segmented into North America, Europe, Asia Pacific, and the Middle East and Africa.
Key Players
the key players in the global antifungal treatment market are Pfizer Inc. (U.S), Merck & Co., Inc. (U.S), Sanofi (France), Novartis AG (Switzerland), Bayer AG (Germany), and Astellas (Japan).
Regional Analysis
North America has been accounted for the largest region in the global antifungal treatment market over the forecast period, owing to the growing occurrence of immunological diseases and increasing healthcare expenditure by the governments.
Europe has been assessed as the second major market and holds a significant market share in the global antifungal treatment market. The European market for antifungal treatments is projected to grow extensively through the forecast period, owing to the accessibility of advanced treatment facilities, skilled medical experts, and the adoption of new therapies for antifungal treatments.
Asia Pacific region has been assessed as the fastest growing region of the global antifungal treatment market, owing to the alarmingly high prevalence of HIV diseases in this region. Additionally, the increasing awareness about antifungal treatment methods and availability of advanced treatment techniques has been expected to drive the market in the Asia Pacific region over the forecast period. In the Asia Pacific region, the market has been assessed to witness lucrative opportunities in emerging economies such as China and India, with China leading the market growth with a CAGR of 5.24% by 2023.
The Middle East & Africa has been projected to show moderate growth over the forecast period, due to significant factors such as lack of awareness concerning the anti-fungal treatment, limited access and availability of basic healthcare treatment facilities, and low income of consumers, among others.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian